Lindberg, Karolina <br/><br/>
Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.  [electronic resource] 

 -  Breast cancer research : BCR  Apr 2011 
 - R43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr2865  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Biomarkers, Tumor<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Class I Phosphatidylinositol 3-Kinases<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Estrogen Receptor beta--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Neuregulin-1--metabolism<br/>PTEN Phosphohydrolase--genetics<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Receptor, ErbB-2--genetics<br/>Receptor, ErbB-3--genetics<br/>Signal Transduction<br/>Tamoxifen--pharmacology<br/>Up-Regulation